GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Omnimmune Holdings Inc (GREY:OMMH) » Definitions » EV-to-FCF

Omnimmune Holdings (Omnimmune Holdings) EV-to-FCF : -0.00 (As of Jun. 02, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Omnimmune Holdings EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Omnimmune Holdings's Enterprise Value is $0.00 Mil. Omnimmune Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2010 was $-0.57 Mil. Therefore, Omnimmune Holdings's EV-to-FCF for today is -0.00.

The historical rank and industry rank for Omnimmune Holdings's EV-to-FCF or its related term are showing as below:

OMMH's EV-to-FCF is not ranked *
in the Biotechnology industry.
Industry Median: 8.21
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-02), Omnimmune Holdings's stock price is $0.0001. Omnimmune Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2010 was $-0.190. Therefore, Omnimmune Holdings's PE Ratio for today is At Loss.


Omnimmune Holdings EV-to-FCF Historical Data

The historical data trend for Omnimmune Holdings's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omnimmune Holdings EV-to-FCF Chart

Omnimmune Holdings Annual Data
Trend May07 May08 Dec09
EV-to-FCF
- -149.96 -14.66

Omnimmune Holdings Quarterly Data
May07 Aug07 Nov07 Feb08 May08 Aug08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Omnimmune Holdings's EV-to-FCF

For the Biotechnology subindustry, Omnimmune Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omnimmune Holdings's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Omnimmune Holdings's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Omnimmune Holdings's EV-to-FCF falls into.



Omnimmune Holdings EV-to-FCF Calculation

Omnimmune Holdings's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=0.001/-0.57
=-0.00

Omnimmune Holdings's current Enterprise Value is $0.00 Mil.
Omnimmune Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2010 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Omnimmune Holdings  (GREY:OMMH) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Omnimmune Holdings's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0001/-0.190
=At Loss

Omnimmune Holdings's share price for today is $0.0001.
Omnimmune Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2010 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.190.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Omnimmune Holdings EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Omnimmune Holdings's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Omnimmune Holdings (Omnimmune Holdings) Business Description

Traded in Other Exchanges
N/A
Address
4600 Post Oak Place, Suite 352, Houston, TX, USA, 77027
Website
Omnimmune Holdings Inc is a development-stage biotechnology company, which is engaged in integrating complementary cancer therapeutic, diagnostic and prognostic technologies.

Omnimmune Holdings (Omnimmune Holdings) Headlines

No Headlines